We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Cryoport Inc. and Medipal Holdings Corporation have announced a multi-year strategic business alliance agreement to create an integrated regenerative medicine supply chain solution in Japan.